$6.47
0.00%
Nasdaq, Wed, Sep 16 2026.
ISIN
AGP8696W1045
Symbol
SVA

Sinovac Biotech Ltd. Stock price

$6.47
+0.00 0.00% 1M
+0.00 0.00% 6M
+0.00 0.00% YTD
+0.00 0.00% 1Y
+0.00 0.00% 3Y
+0.00 0.00% 5Y
+0.67 11.55% 10Y
+3.73 136.13% 20Y
Nasdaq, Closing price Wed, Sep 16 2026
+0.00 0.00%
ISIN
AGP8696W1045
Symbol
SVA
Industry

Is Sinovac Biotech Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
positive
Cash
$5.5b
Shares outstanding
71.9m
Valuation (TTM | estimate)
P/E
negative
P/S
- | -
EV/Sales
- | -
EV/FCF
-
P/B
-
Dividends
DPS
$55.00
Yield 1Y | 5Y
0.0% | 0.0%
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
-6,626.5% | 22,000.0%
Increased
1 Year
Financials (TTM | estimate)
Revenue
$402.8m | -
EBITDA
$-119.2m
EBIT
$-216.9m
Net Income
$-98.3m
Free Cash Flow
$-565.6m
Growth (TTM | estimate)
Revenue
8.8% | -
EBITDA
60.5%
EBIT
45.1%
Net Income
-222.6%
Free Cash Flow
-13,043.3%
Margin
Gross
68.5%
EBITDA
-29.6%
EBIT
-53.9%
Net
-24.4%
Free Cash Flow
-140.4%
Financial Health
Equity Ratio
52.0%
Return on Equity
-1.3%
ROCE
-3.1%
ROIC
-10.6%
Debt/Equity
0.1
More
EPS
$-1.4
FCF per Share
$-7.9
Short interest
0.3%
Employees
-
Rev per Employee
-

Financial data from Sinovac Biotech Ltd.

Jun '26
+/-
%
403 403
9% 9%
100%
- Direct Costs 127 127
15% 15%
31%
276 276
25% 25%
69%
- Selling and Administrative Expenses 321 321
14% 14%
80%
- Research and Development Expense 172 172
32% 32%
43%
-119 -119
60% 60%
-30%
- Depreciation and Amortization 98 98
4% 4%
24%
EBIT (Operating Income) EBIT -217 -217
45% 45%
-54%
Net Profit -98 -98
223% 223%
-24%

In millions USD.

Don't miss a Thing! We will send you all news about Sinovac Biotech Ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sinovac Biotech Ltd. Stock News

Neutral
Business Wire
about one month ago
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced it filed its unaudited financial results for the six months ended June 30, 2026 with the U.S. Securities and Exchange Commission. An electronic copy of the financial results can be accessed at the Company's website at www.sinovac.c...
Neutral
Business Wire
2 months ago
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company's previously declared special cash dividend. The Company previously announced a special cash dividend of ...
Neutral
Business Wire
3 months ago
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the "Notification Letter"), from Hearing Advisor of The Nasdaq Stock Market LLC., indicating that the Company has regained compliance with Listing Rule 5250(c)(1) and that...
More Sinovac Biotech Ltd. News

Company Profile

Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.

Head office Antigua and Barbuda
CEO Mr. Yin
Founded 1993
Website www.sinovac.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today